NCT02655679View on ClinicalTrials.gov

An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 15, 2015

Primary Completion Date

September 9, 2016

Study Completion Date

September 9, 2016

Conditions
Dermatitis, Atopic
Interventions
DRUG

VTP-38543

VTP-38543 topical cream

OTHER

Vehicle with Transcutol®P

Vehicle matching VTP-38543 cream with Transcutol®P

OTHER

Vehicle without Transcutol®P

Vehicle matching VTP-38543 cream without Transcutol®P

Trial Locations (12)

10155

Skin Specialty Dermatology, New York

19103

Paddington Testing Company, Inc, Philadelphia

27612

Wake Research Associates, LLC, Raleigh

48059

Hamzavi Dermatology, Fort Gratiot

60118

Dundee Dermatology, West Dundee

T2G1B1CA

Kirk Barber Research, Calgary

T5K 1X3

Stratica Medical Inc, Edmonton

L3P 1X2

Lynderm Research Inc, Markham

L4B 1A5

The Center for Dermatology / Institution, Richmond Hill

N8W 5L7

Windsor Clinical Research Inc, Windsor

J2B 5L4

Dr Isabelle Delorme Inc, Drummondville

H2K4L5

Innovaderm Research, Montreal

All Listed Sponsors
lead

Vitae Pharmaceuticals, Inc.

INDUSTRY

NCT02655679 - An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis | Biotech Hunter | Biotech Hunter